Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

77.69 +3.04 (+4.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,645,996
Open 74.78
Bid (Size) 77.75 (1)
Ask (Size) 78.00 (1)
Prev. Close 74.65
Today's Range 74.50 - 77.77
52wk Range 62.34 - 142.00
Shares Outstanding 400,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Iris Energy, and DexCom and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
S&P 500, Nasdaq 100 Extend 8-Session Winning Streak As Wall Street Jitters 'Go Poof': Monday's Key Stock Movers
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
-36.88%
-36.88%
1 Month
-30.42%
-30.42%
3 Month
-40.55%
-40.55%
6 Month
-34.09%
-34.09%
1 Year
-25.78%
-25.78%

More News

Read More
2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200
Via The Motley Fool
2 Growth Stocks to Buy at a Discount
Via The Motley Fool
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
Via Benzinga
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers
Via Talk Markets
S&P 500, Nasdaq 100 Mark Seventh Straight Positive Session, Strongest Week Since October 2023: Friday's Top Movers
Via Benzinga
Topics Stocks
Exposures US Equities
1 Growth Stock Down 43% to Buy Right Now
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Top 3 Stocks to Watch: Options Traders Bet on Big Gains
Via MarketBeat
Topics Stocks
Exposures US Equities
Should You Buy the 3 Worst Nasdaq 100 Stocks Since the Tech Sector Selloff?
Via InvestorPlace
DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?
Via The Motley Fool
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
Via Benzinga
These Stocks Just Dropped by 40% and 15% -- Should You Buy the Dip?
Via The Motley Fool
Chips, Glorious Chips!
Via The Motley Fool
Is It Time to Buy July's Worst-Performing Nasdaq Stocks?
Via The Motley Fool
Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
Via MarketBeat
Topics Bonds ETFs
Exposures Debt Markets
Down 40% in 1 Day, Is DexCom Stock Still a Buy?
Via The Motley Fool
Bragar Eagel & Squire, P.C. Is Investigating Nano Nuclear, Iris Energy, Ford, and DexCom and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Via Benzinga
Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Via MarketBeat
The Law Offices of Frank R. Cruz Announces Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.